DOCS vs WAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 01, 2026

DOCS

35.8
AI Score
VS
WAY Wins

WAY

42.7
AI Score

Investment Advisor Scores

DOCS

36score
Recommendation
AVOID NEW MONEY

WAY

43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DOCS WAY Winner
Forward P/E 25.4453 14.9477 WAY
PEG Ratio 0.5895 0 Tie
Revenue Growth 7.3% 18.1% WAY
Earnings Growth -51.9% 16.7% WAY
Tradestie Score 35.8/100 42.7/100 WAY
Profit Margin 25.5% 11.2% DOCS
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD WAY

Relative Price Performance (Last 90 Days)

DOCS 1M: +6.0% · 3M: +29.7% WAY 1M: +9.9% · 3M: +19.4%

Current Technical Phase

DOCS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.9% over 20 days), RSI 54

RSI (14): 54.1 · Price: $32.42

WAY

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.0% over 20 days), RSI 59

RSI (14): 59.3 · Price: $29.30

Fundamentals Snapshot

Metric DOCS WAY
Market Cap — —
Forward P/E 20.0 15.5
Trailing P/E 45.7 42.3
Revenue (TTM) — —
Revenue Growth 0.0% 0.2%
Gross Margin 0.9% 0.7%
Operating Margin 0.3% 0.2%
EPS 0.72 0.69
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, WAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.